Kiacta eprodisate disodium regulatory update

EMEA's CHMP issued a negative opinion on an MAA from NRM for Kiacta eprodisate to treat amyloid A (AA) amyloidosis. CHMP said the opinion was due to insufficient data demonstrating the efficacy of Kia...